Overall, increased expression of ZFX in CML CD34+ cells modulates the growth and IM response of these cells, and ZFX promotes leukemogenesis induced by the BCR/ABL oncoprotein in a model of BaF3 cells. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.